VNRX — VOLITIONRX LTD
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Measured signals that fired on VNRX
| date | signal | measured base rate |
|---|---|---|
| 2026-04-07 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-03-17 | Plummer Nicholas GC - Volition Diagnostics | Shares withheld for tax | 7.0K | 0.19 | 1.3K |
| 2026-03-17 | Micallef Jacob Vincent Chief Scientific Officer | Shares withheld for tax | 5.3K | 0.19 | 1.0K |
| 2026-03-17 | Forterre Gael Chief Commercial Officer | Shares withheld for tax | 5.3K | 0.19 | 998 |
| 2026-03-17 | Rootsaert Rodney Gerard Secretary | Shares withheld for tax | 3.9K | 0.19 | 750 |
| 2026-03-01 | Plummer Nicholas GC - Volition Diagnostics | Shares withheld for tax | 5.9K | 0.21 | 1.2K |
| 2026-03-01 | Rootsaert Rodney Gerard Secretary | Shares withheld for tax | 3.3K | 0.21 | 697 |
| 2026-03-01 | Forterre Gael Chief Commercial Officer | Shares withheld for tax | 2.3K | 0.21 | 479 |
| 2026-02-26 | Rubin Ethel Director | Grant or award | 178.0K | 0.00 | 0 |
| 2026-02-26 | Nguyen Kim Director | Grant or award | 178.0K | 0.00 | 0 |
| 2026-02-26 | Forterre Gael Chief Commercial Officer | Grant or award | 149.0K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Lagoda Investment Management, L.P. | 3.3M | 16.1M |
| GEODE CAPITAL MANAGEMENT, LLC | 248.5K | 1.2M |
| VANGUARD CAPITAL MANAGEMENT LLC | 204.8K | 1.0M |
| LUMINUS MANAGEMENT LLC | 201.0K | 995.0K |
| STATE STREET CORP | 137.3K | 679.9K |
| VANGUARD FIDUCIARY TRUST CO | 101.5K | 502.7K |
| BlackRock, Inc. | 90.1K | 446.2K |
| NORTHERN TRUST CORP | 52.4K | 259.6K |
| Silverberg Bernstein Capital Management LLC | 50.7K | 251.2K |
| Wealthspire Advisors, LLC | 44.4K | 220.0K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- VolitionRx outlines September DETECSEPS start while targeting $5M feline milestone publication · 2026-08-14
- Volitionrx LTD (VNRX) filed form 8-K · 2026-08-13 · SEC EDGAR
- VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update · 2026-08-13
- VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update · 2026-08-13
- VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update · 2026-08-11
- VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update · 2026-08-11
Ask the AI about VNRX
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →